View Older Stories

Jan 28, 2026 06:20AM Barclays Starts Vertex (VRTX) at Overweight, 'bullish into 2026 readouts'

Jan 23, 2026 04:44AM Vertex (VRTX) PT Raised to $530 at Evercore ISI

Jan 22, 2026 05:05AM RBC Capital Upgrades Vertex (VRTX) to Outperform

Jan 12, 2026 06:18AM Bernstein SocGen Group Upgrades Vertex (VRTX) to Outperform

Jan 12, 2026 04:07AM Vertex reports drug pipeline progress ahead of investor meetings

Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC

Jan 6, 2026 05:35AM Wolfe Research Upgrades Vertex (VRTX) to Outperform

Jan 2, 2026 10:52AM BofA unveils its top 10 U.S. ideas for Q1 2026

Jan 2, 2026 08:43AM BofA: 'our Top 10 Ideas include nine Buys and one Underperform across nine industries'

Dec 18, 2025 06:24AM BofA: 'Top SMid Biotech Picks Argenx, KalVista, Ocular, and Vertex'

Dec 12, 2025 10:17AM BMO Capital Reiterates Outperform Rating on Vertex (VRTX)

Dec 8, 2025 02:54AM Vertex shares new CASGEVY data for children ages 5-11 at medical meeting

Dec 3, 2025 03:51AM Morgan Stanley Upgrades Vertex (VRTX) to Overweight

Nov 12, 2025 04:14PM Scotiabank Starts Vertex (VRTX) at Sector Outperform

Nov 11, 2025 10:50AM Vertex In 'advanced' Talks With Large Pbm On Journavx Coverage - Bloomberg

Nov 10, 2025 10:01AM Stifel Reiterates Hold Rating on Vertex (VRTX)

Nov 4, 2025 09:26AM Vertex (VRTX) PT Lowered to $445 at Stifel

Nov 4, 2025 09:04AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)

Nov 4, 2025 08:58AM Vertex (VRTX) PT Lowered at BMO Capital Amid 'Greater Near-Term Complexity'

Nov 4, 2025 08:11AM Vertex (VRTX) PT Lowered to $466 at Bernstein SocGen Group

Nov 3, 2025 04:06PM Vertex Pharma (VRTX) Tops Q3 EPS by 23c, provides guidance

Oct 31, 2025 10:26AM Vertex Pharma (VRTX) call put ratio 15 call to 1 put into quarter results

Oct 31, 2025 04:25AM Vertex Pharma (VRTX) call put ratio 1 call to 1.9 puts into quarter results

Oct 27, 2025 07:41AM Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'

Oct 23, 2025 09:01AM VERTEX presents data on cystic fibrosis drugs at conference

Oct 22, 2025 04:21AM Citizens Reiterates Vertex (VRTX) at Market Outperform Rating; Management Sees Revenue Above Consensus

Oct 17, 2025 09:04AM Vertex receives FDA rolling review for kidney disease drug povetacicept

Oct 12, 2025 03:00PM Biotech stocks: Q3 earnings preview

Oct 9, 2025 09:25AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)

Oct 8, 2025 09:24AM Vertex (VRTX) PT Raised to $423 at RBC Capital

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

Sep 25, 2025 07:45AM Vertex receives FDA breakthrough therapy designation for kidney drug

Sep 25, 2025 06:20AM Leerink Partners Upgrades Vertex (VRTX) to Outperform

Sep 18, 2025 08:32AM Vertex secures Italian reimbursement deal for gene therapy CASGEVY

Aug 11, 2025 05:08AM Goldman Sachs Reiterates Buy Rating on Vertex (VRTX)

Aug 8, 2025 05:40AM Vertex (VRTX) PT Lowered to $34 at BofA Securities

Aug 6, 2025 06:51AM Vertex (VRTX) PT Lowered to $411 at Canaccord Genuity

Aug 5, 2025 09:44AM Vertex (VRTX) PT Lowered to $405 at RBC Capital Amid Setbacks

Aug 5, 2025 09:34AM Vertex (VRTX) PT Lowered to $530 at BMO Capital

Aug 5, 2025 09:28AM Vertex (VRTX) PT Lowered to $455 at Stifel

Aug 5, 2025 09:27AM Vertex (VRTX) PT Raised to $471 at Bernstein SocGen Group

Aug 5, 2025 09:04AM Vertex (VRTX) PT Lowered to $485 at Cantor Fitzgerald

Aug 5, 2025 07:41AM Vertex (VRTX) PT Lowered to $490 at Truist Securities

Aug 5, 2025 07:11AM Vertex (VRTX) PT Lowered to $478 at H.C. Wainwright

Aug 5, 2025 06:42AM Vertex (VRTX) PT Lowered to $458 at Leerink Partners

Aug 5, 2025 06:11AM Vertex (VRTX) PT Lowered to $553 at UBS

Aug 4, 2025 04:36PM After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more

Aug 4, 2025 04:03PM Vertex Pharma (VRTX) Tops Q2 EPS by 25c, Beats on Revenue; Offers FY25 Revenue Guidance

Aug 1, 2025 10:58AM Vertex Pharma (VRTX) call put ratio 1.4 calls to 1 put into quarter results

View Older Stories